This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Identify dividend ETFs with competitive fees and solid value. Learn key criteria and compare options to optimize your costs today.
27,814 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Chip Wilson, founder of Lululemon, remains a disruptive voice as he pushes for board changes while the company prepar...
A big investor just bought millions of Grindr shares after the stock plunged. This article breaks down why grindr sto...
A famous investor's concise message has sparked fresh discussions about market risk. This article breaks down what th...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
When markets punish uncertainty, contrarian investors can find hidden upside. This article highlights three strugglin...
An upbeat quarterly report sent accelerant holdings stock skyrocketed higher by double digits. This piece breaks down...
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
Micron Technology soared 326% in just 12 months, but a sky-high gain doesn’t guarantee a smart buy. This guide breaks...
I’ve shifted my stance on MSFT stock as the AI era deepens, driven by Azure momentum, productivity platforms, and str...
AI momentum is reshaping markets. This guide dives into what best artificial intelligence stocks to buy now, how to s...
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...